Accordingly, this pilot study was aimed at evaluating if some clinical characteristics and interleukin-6 (IL-6), a marker of inflammation, could be useful to describe frailty in older patients with the arrhythmia. This evidence concerns the gene IL6 and cardiac arrhythmia.